|
⚲
|
| Keyboard |
| Eric Richman | |
|---|---|
| Firm | |
| Address | 350 Technology Drive Pittsburgh, PA 15219 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Neubase Therapeutics Inc | 021-486254 | Director | 5.0 M of 5.0 M |
||
| Gain Therapeutics Inc | 021-372084 | Executive Officer | 10.0 M of 10.0 M |
||
| Zyversa Therapeutics Inc | 021-352367 | Director | 1.3 M of 20.0 M |
||
| Infuse Holdings Inc | 021-348131 | Director | 8.1 M of 8.1 M |
||
| Infuse Holdings Inc | 021-348132 | Director | 1.0 M of 1.0 M |
||
| Labconnect Holdings Inc | 021-288710 | Director | 33.4 M of 34.9 M |
||
| Therabron Therapeutics Inc | 021-277047 | Director | 2.3 M of 6.0 M |
||
| ADMA Biologics Inc | 021-189666 | Director | |||
| ADMA Biologics Inc | 021-174103 | Director | |||
| ADMA Plasma Biologics Inc | 021-174101 | Director | 17.6 M of 17.6 M |
||
| Pharmathene Inc | 021-150748 | Executive Officer | 9.9 M of 22.6 M |
||
| Pharmathene Inc | 021-124075 | Executive Officer | 19.3 M of 19.3 M |
||